- Home
- RDFN vs CDNA Comparison
RDFN vs CDNA Comparison
Compare RDFN & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RDFN
- CDNA
- Stock Information
- Founded
- RDFN 2002
- CDNA 1998
- Country
- RDFN United States
- CDNA United States
- Employees
- RDFN N/A
- CDNA N/A
- Industry
- RDFN Real Estate
- CDNA Medical Specialities
- Sector
- RDFN Finance
- CDNA Health Care
- Exchange
- RDFN Nasdaq
- CDNA Nasdaq
- Market Cap
- RDFN 1.3B
- CDNA 1.0B
- IPO Year
- RDFN 2017
- CDNA 2014
- Fundamental
- Price
- RDFN N/A
- CDNA $19.24
- Analyst Decision
- RDFN Hold
- CDNA Buy
- Analyst Count
- RDFN 11
- CDNA 6
- Target Price
- RDFN $10.85
- CDNA $30.33
- AVG Volume (30 Days)
- RDFN 7.9M
- CDNA 929.2K
- Earning Date
- RDFN 08-05-2025
- CDNA 07-30-2025
- Dividend Yield
- RDFN N/A
- CDNA N/A
- EPS Growth
- RDFN N/A
- CDNA N/A
- EPS
- RDFN N/A
- CDNA 1.07
- Revenue
- RDFN $1,038,527,000.00
- CDNA $346,421,000.00
- Revenue This Year
- RDFN N/A
- CDNA $13.31
- Revenue Next Year
- RDFN $5.32
- CDNA $15.46
- P/E Ratio
- RDFN N/A
- CDNA $17.87
- Revenue Growth
- RDFN 5.11
- CDNA 25.92
- 52 Week Low
- RDFN $5.49
- CDNA $14.09
- 52 Week High
- RDFN $15.29
- CDNA $34.84
- Technical
- Relative Strength Index (RSI)
- RDFN 12.18
- CDNA 54.70
- Support Level
- RDFN $11.00
- CDNA $18.57
- Resistance Level
- RDFN $11.45
- CDNA $19.84
- Average True Range (ATR)
- RDFN 0.41
- CDNA 0.77
- MACD
- RDFN -0.73
- CDNA -0.06
- Stochastic Oscillator
- RDFN 0.00
- CDNA 60.53
About RDFN Redfin Corporation
Redfin Corp is a residential real estate broker. It pairs its agents with the technology to create a service that is faster and costs less. The company meets customers through a listings-search website and mobile application. The company uses the same combination of technology and local service to originate mortgage loans and offer title and settlement services. It has five operating segments real estate services, rentals, mortgage, title, and monetization. The company generates the majority of its revenue from Real estate services.
About CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.